Office Bearers and Council


Professor Mark Forwood

Mark Forwood

Griffith University Gold Coast
School of Medical Science
Griffith University
QLD.  4222.
P: 61 07/5552 7305


Professor Forwood was appointed as the Foundation Chair of Anatomy at Griffith University in 2009, and Head, School of Medical Science from 2013 to 2021. His laboratory studies skeletal adaptation, mechanotransduction and bone quality, funded by grants from National Health and Medical Research Council since 1996. He was a NHMRC Fellow at Indiana University with David Burr and Charles Turner at IUPUI from 1991-1994. Following his Fellowship, Prof Forwood returned to the The University of Queensland, where he continued his research in skeletal biology and taught gross and musculoskeletal anatomy. Mark was first elected to ANZBMS Council in 1997 and became Treasurer from 1999-2005. He has been a member of the Board of Directors of the International Federation of Musculoskeletal Research Societies since 2017 and Chair of the IFMRS International Education Working Group. He is on the Editorial Board of Bone and was a section editor for Current Osteoporosis Reports. In 2016, he was elected as a Fellow of the Queensland Academy of Arts and Sciences, and in 2019 a Fellow of the ASBMR.



Associate Professor Rachel Davey

Rachel Davey



















Associate Professor Rachel A Davey, PhD
Head, Molecular Endocrinology and Musculoskeletal Research Group
Department of Medicine, Austin Health
The University of Melbourne
Level 7, Lance Townsend Building
Studley Road
Heidelberg Victoria 3074
Ph: 61 3 9496 5507
Fax: 61 3 9457 5485

Associate Professor Rachel Davey completed her PhD in Physiology at The University of Adelaide in 1998, studying the effects of estrogens and androgens on bone cell metabolism. Associate Professor Davey is currently Head of the Molecular Endocrinology and Musculoskeletal Research Group in the Department of Medicine, Austin Health at the University of Melbourne.

Associate Professor Davey’s research focusses on the cellular and molecular pathways through which hormones act in the musculoskeletal system with a particular focus on androgens and calcitonin. She has over 50 publications spanning areas of bone and muscle biology and metabolism. In recognition of her research and teaching achievements, she was the first Australian to be awarded the American Society of Bone and Mineral Research Early Career Teaching Award (2008), the inaugural recipient of the Endocrine Society of Australia Mid-Career Award (2009) and the recipient of an ANZBMS mid-career fellowship in 2017.

Scientific Involvement (selected):
Member ANZBMS, 1997-current.
Member ASBMR, 2004 – current.
Member ESA, 1999 – current.
Co-chair of the Programme Organising Committee, ANZBMS Scientific Meeting, 2018 and 2019.
Member of the Programme Organising Committee and Local Organising Committee, ANZBMS 2013.




Professor Mark Cooper

Mark Cooper

University of Sydney, Anzac Research Institute
Concord Repatriation General Hospital
Hospital Road
Concord.  NSW.  2139.

Mark Cooper is Prof of Medicine and Head of Medicine at the Concord Clinical School, University of Sydney. He heads the Adrenal Steroid Lab at the ANZAC Research Institute. Until 2012 he was a Senior Lecturer at the University of Birmingham, UK. and metabolic bone physician at the Royal Orthopaedic Hospital, one of the largest orthopaedic hospitals in Europe. His clinical and research interests include adrenal steroid physiology and metabolic bone disease. In particular, he examines the role that glucocorticoid metabolism plays in normal physiology, inflammatory arthritis and glucocorticoid induced osteoporosis. He was previously the Bertram Abraham’s Lecturer in Physiology at the Royal College of Physicians of London. He has served on committees for the ASBMR and ECTS. He continues to combine a clinical practice with a basic/translational research group.




Prof. Gustavo Duque MD, PhD, FRACP, FGSA


Prof. Gustavo Duque MD, PhD, FRACP, FGSA

Sunshine Hospital, 176 Furlong Road, St Albans, VIC, 3021, Australia 

T +61 3 8395 8121 | E

Prof. Gustavo Duque MD, PhD, FRACP, FGSA is a geriatrician and a clinical and biomedical researcher with special interest in the mechanisms and treatment of osteoporosis, sarcopenia and frailty in older persons. His initial training included Internal Medicine at Javeriana University (Colombia) and Geriatric Medicine, which he completed at McGill University in Montreal (Canada). Subsequently, he obtained his PhD at McGill University in 2003 with a thesis entitled ‘Molecular Changes of the Aging Osteoblast’ under the supervision of Dr. Richard Kremer. Prof. Duque's major research interests include the elucidation of the mechanisms and potential new treatments for age-related bone loss, osteoporosis, sarcopenia and frailty. He is also looking at the effect of vitamin D, exercise and proteins on bone and muscle mass. He is currently Chair of Medicine and Director of the Australian Institute for Musculoskeletal Science (AIMSS) at the University of Melbourne and Western Health. He is also Director of the Fracture Care and Prevention Program at Western Health (Melbourne). As part of this Program, Prof. Duque implemented a Falls and Fractures clinic at Sunshine Hospital where patients are assessed for falls and fractures risk in a comprehensive manner.



Professor Natalie Sims


Natalie Sims

St Vincents' Institute
Fitzroy.  VIC. 3065.
T: 03/9231 2555

Deputy Director, St. Vincent’s Institute, Melbourne, Australia

Prof. Natalie Sims directs the Bone Cell Biology and Disease Unit at St. Vincent’s
Institute and is an NHMRC Senior Research Fellow and Professorial Fellow at The University of Melbourne. She completed her PhD in 1995 at the University of Adelaide, and started her own laboratory in Melbourne in 2001 after postdoctoral studies at the Garvan Institute (Sydney) and Yale University. Her work has defined the roles of Oncostatin M,
Cardiotrophin 1, and Leukemia Inhibitory Factor on the development and maintenance of the skeleton, using genetically altered mouse models and in vitro systems. She has worked closely with Prof TJ Martin on developing theories of bone cell communication, particularly with respect to the concept of “coupling”. Her current work continues to focus on paracrine control of the skeleton, particularly the way parathyroid hormone, IL-6 and STAT1/3 signalling influence bone formation and destruction. She has >100 original research publications and many invited chapters and reviews. Prof Sims is an Associate Editor of both the Journal of Bone and Mineral Research and Endocrine Reviews, and serves on the Editorial Board of the Journal of Biological Chemistry. Her work has been recognised by the American Society of Boen and Mineral Research (ASBMR) Fuller Albright Award (2010), the International Bone and Mineral Society Herbert A Fleisch Award (2013) and the ASBMR Paula Stern Award (2020).




Dr Melissa Cantley PhD 

Mark Cooper

NHMRC Early Career Research Fellow | Faculty of Health and Medical Sciences
School of Biomedicine
The University of Adelaide
Myeloma Research Laboratory 
Precision Medicine Theme, Cancer Program - Level 5 South
SAHMRI, North Tce 
Adelaide, Australia
Phone: +61 9 8124 4694

Dr Melissa Cantley completed her PhD in 2013 at the University of Adelaide with a project focussed on pathological bone remodelling. In 2014 Melissa was awarded a NHMRC Early Career Fellowship to work with Professor Zannettino in the Myeloma Research Laboratory at the University of Adelaide, located at the South Australian Health and Medical Research Institute (SAHMRI). Dr Cantley’s research interests revolve around bone cell biology and role of the complex bone microenvironment in disease. This has included in chronic inflammatory diseases such as rheumatoid arthritis and periodontitis where she has made significant research contributions in therapeutic targeting of pathogenic bone loss. Dr Cantley's current research is focussed on the blood cancer multiple myeloma and understanding the progression from pre-cancerous stages to cancerous myeloma. This involves unravelling the role of the complex bone marrow microenvironment in disease progression and discovering novel biomarkers that can be used to predict risk of progression in patients with the pre-cancerous stages of disease.  Dr Cantley has been Co-Chair of the ANZBMS Early Career Investigator Committee (ECIC) over the last two years and was a member of the Inaugural ANZBMS Early Career Investigator Newsletter Editorial Board (2019-2021). Dr Cantley has also been a member of the ANZBMS Program Organising Committee (POC) (2020-2021). Dr Cantley is a Director on the Australian Society for Medical Research (ASMR) National Board.

Assoc Professor Cherie Chiang

Assoc Professor Cherie Chiang


Endocrinologist & Stream Leader Endocrine Chemical Pathology, Department of Diabetes and Endocrinology, Royal Melbourne Hospital.

Chemical Pathologist, Department of Pathology, Royal Melbourne Hospital.

Endocrinologist, Austin Hospital & Peter MacCallum cancer Centre Honorary Senior Fellow, The University of Melbourne

P: Department of Pathology, Royal Melbourne Hospital, Parkville VIC 3050.

T: + 613 93427000

F: + 613 93427360 E:

Dr Chiang graduated with honours from Monash University. She completed her membership examination for Australasian Association of Clinical Biochemists in 2006 and her dual fellowships in FRACP and FRCPA in 2008. She was the recipient of the ASBMR Young Investigator Award in 2015. She completed her Doctor of Medicine (University of Melbourne) Doctorate by Research in 2018 on The Role of Androgens Acting via the Androgen Receptor in Osteoblasts to Regulate Bone Cell Metabolism. Her research interests and publications include Bone Turnover Markers, Vitamin D, bone microarchitecture and Atypical Femoral Fractures. She has broad clinical experience in management of skeletal disease in cancer, setting up of Fracture Liaison Service, and Bone Densitometry reporting. She is a RCPA examiner and the chair of the Harmonisation of Endocrine Dynamic Testing Working Party.


Assoc Professor Dawn Coates

Assoc Professor Dawn Coates

Faculty of Dentistry | Te Kaupeka Pūniho 
Sir John Walsh Research Institute 
University of Otago | Te Whare Wānanga o Otāgo 
New Zealand | Aotearoa
Phone: +64 27 4891239
Dr Coates is a molecular and cellular biologist with 28 years of experience in osteogenesis, angiogenesis, and stem cell biology. After completing a PhD at Otago University she undertook postdoctoral positions with AgResearch (Wallaceville, NZ) and at Cambridge University. Dr Coates is Deputy Associate Dean of Research within the Dental Faculty (University of Otago, NZ), and is Director of DEnTRegen (Dental Engineering and Tissue Regeneration), a programme which produces novel bioengineered constructs for bone and tissue regeneration. Dr Coates has a focus on 3D-bioprinting of constructs and the development of novel bovine graft materials for bone regeneration. These materials are modified to provide additional benefit with the addition of antimicrobial agents such as nanosilver particles and triketones. Research on BRONJ (Bisphosphonate-Related Osteonecrosis of the Jaw) and the angiogenic and osteogenic genes involved, identified geranylgeraniol as a drug that can correct the molecular pathway affected in this serious condition. Stem cell projects include research with dental pulp stem cells, adipose-derived stem cells, periosteal stem cells, and deer antler stem cells as a model system. The use of proteomics and gene analysis in combination in vitro assays has enable new insights into these fascinating cells.


A/Professor Josh Lewis

Mark Cooper

Edith Cowan University

270 Joondalup Drive
Joondalup WA 6027

Perth, WA


Josh is a National Heart Foundation Future Leader Fellow at Edith Cowan University and the research program lead for the newly formed Institute for Nutrition Research. Josh leads the Perth Longitudinal Study of Ageing Women and the disorders of mineralisation research group with a focus on the shared epidemiology of osteoporosis and cardiovascular disease. His vascular-musculoskeletal research program spans basic, clinical and translational fields and includes genetics, biomarkers as well as modifiable lifestyle factors. This research seeks to identify individuals with clinically unrecognised disease so that early nutritional and lifestyle intervention can be implemented to prevent the onset of clinical disease.


Dr Michelle McDonald

Mark Cooper

Garvan Institute

384 Victoria St
Darlinghurst.  NSW. 
Phone: 02-9295 8247


Dr Michelle McDonald’s research careers spans over 19 years, attaining her PhD in 2008. She is currently Group Leader of the Bone Microenvironment Group at The Garvan Institute, Sydney, Australia. Through the development of a novel intravital imaging technique her research has allowed, visualisation and fate tracking of dormant and actively growing tumour cells within living bone, as well as visualisation of bone cells in real timeThis approach has revealed previously unappreciated bone osteoclast dynamics, and uncovering mechanisms behind unexpected clinical responses to anti-resorptive therapies, which was recently accepted in Cell. Combined with her experience using therapeutic agents to modulate bone cell activity, her group is working to define how these agents can be repurposed to prevent tumour-induced bone destruction and prevent tumour growth through regulating the bone micro-environment. Michelle regularly perform peer reviews, sits on the editorial boards and holds positions on international scientific committees.